These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38773287)

  • 1. Trials that infected people with common colds can inform today's COVID-19 challenge trials.
    Ewbank J
    Nature; 2024 May; 629(8013):757. PubMed ID: 38773287
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond Omicron: what's next for COVID's viral evolution.
    Callaway E
    Nature; 2021 Dec; 600(7888):204-207. PubMed ID: 34876665
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses - are we our own worst enemy?
    Wong LR; Perlman S
    Nat Rev Immunol; 2022 Jan; 22(1):47-56. PubMed ID: 34837062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Medicine for COVID-19: Phenotype Anarchy or Promise Realized?
    DeMerle K; Angus DC; Seymour CW
    JAMA; 2021 May; 325(20):2041-2042. PubMed ID: 33961002
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for a positive SARS-CoV-2 PCR in patients with common cold symptoms in a primary care setting - a retrospective analysis based on a joint documentation standard.
    Just J; Puth MT; Regenold F; Weckbecker K; Bleckwenn M
    BMC Fam Pract; 2020 Dec; 21(1):251. PubMed ID: 33272198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?
    Pinky L; Dobrovolny HM
    J Med Virol; 2020 Nov; 92(11):2623-2630. PubMed ID: 32557776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the road to ending the COVID-19 pandemic: Are we there yet?
    Case JB; Winkler ES; Errico JM; Diamond MS
    Virology; 2021 May; 557():70-85. PubMed ID: 33676349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cells as a Model of Study of SARS-CoV-2 and COVID-19: A Systematic Review of the Literature.
    Cuevas-Gonzalez MV; Garcia-Perez Á; Gonzalez-Aragon Pineda ÁE; Espinosa-Cristobal LF; Donohue-Cornejo A; Tovar-Carrillo KL; Saucedo-Acuña RA; Cuevas-Gonzalez JC
    Biomed Res Int; 2021; 2021():9915927. PubMed ID: 34458372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2.
    Derakhshan MA; Amani A; Faridi-Majidi R
    ACS Appl Mater Interfaces; 2021 Apr; 13(13):14816-14843. PubMed ID: 33779135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider?
    Arnold CG; Monte AA; Littlefield K; Vest A; Palmer BE
    Viral Immunol; 2021 Dec; 34(10):666-668. PubMed ID: 34491119
    [No Abstract]   [Full Text] [Related]  

  • 11. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 Human Challenge Trials: Rethinking the Recruitment of Healthy Young Adults First.
    Matsui K; Inoue Y; Yamamoto K
    Ethics Hum Res; 2021 May; 43(3):37-41. PubMed ID: 33821569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations, variants and strains of SARS-CoV-2].
    Gamero-de-Luna EJ; Gamero-Estévez E
    Semergen; 2021 Apr; 47(3):208-209. PubMed ID: 33593674
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
    Stefano GB; Kream RM
    Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses.
    Sajid MI; Moazzam M; Cho Y; Kato S; Xu A; Way JJ; Lohan S; Tiwari RK
    Mol Pharm; 2021 Jun; 18(6):2105-2121. PubMed ID: 33945284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and the Common Cold-Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity.
    Abbasi J
    JAMA; 2022 Feb; 327(7):609-610. PubMed ID: 35080593
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
    Majumder J; Minko T
    AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audio Interview: India's Covid-19 Crisis.
    Rubin EJ; Baden LR; Udwadia ZF; Morrissey S
    N Engl J Med; 2021 May; 384(18):e84. PubMed ID: 33951370
    [No Abstract]   [Full Text] [Related]  

  • 19. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics.
    Park YJ; Farooq J; Cho J; Sadanandan N; Cozene B; Gonzales-Portillo B; Saft M; Borlongan MC; Borlongan MC; Shytle RD; Willing AE; Garbuzova-Davis S; Sanberg PR; Borlongan CV
    Stem Cell Rev Rep; 2021 Feb; 17(1):9-32. PubMed ID: 32789802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do childhood colds help the body respond to COVID?
    Brazil R
    Nature; 2021 Nov; 599(7886):540-541. PubMed ID: 34795432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.